Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand

Objective: To estimate the early and long-term mortalities and associated risk factors in adults receiving highly active antiretroviral therapy (HAART) in Thailand. Design: A prospective observational cohort study. Methods: Previously untreated adults starting HAART in 2002-2009 were followed-up in...

Full description

Saved in:
Bibliographic Details
Main Authors: Federica Fregonese, Intira J. Collins, Gonzague Jourdain, Sophie LeCoeur, Tim R. Cressey, Nicole Ngo-Giang-Houng, Sukit Banchongkit, Apichat Chutanunta, Malee Techapornroong, Marc Lallemant
Format: Journal
Published: 2018
Subjects:
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84862126574&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/51901
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
id th-cmuir.6653943832-51901
record_format dspace
spelling th-cmuir.6653943832-519012018-09-04T06:11:27Z Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand Federica Fregonese Intira J. Collins Gonzague Jourdain Sophie LeCoeur Tim R. Cressey Nicole Ngo-Giang-Houng Sukit Banchongkit Apichat Chutanunta Malee Techapornroong Marc Lallemant Medicine Objective: To estimate the early and long-term mortalities and associated risk factors in adults receiving highly active antiretroviral therapy (HAART) in Thailand. Design: A prospective observational cohort study. Methods: Previously untreated adults starting HAART in 2002-2009 were followed-up in 43 public hospitals. Kaplan-Meier probability of survival was estimated up to 5 years of therapy. Factors associated with early (≤6 months) and long-term (>6 months) mortalities were assessed using Cox regression analyses. Results: A total of 1578 adults received HAART (74% women; median age, 33 years; CD4 cell count, 124/mL), with a median followup of 50 months (interquartile range, 41-66). Eighty-nine patients (6%) died (37 occurred ≤6 months and 52 occurred >6 months) and 183 (12%) were lost to follow-up. Probability of survival [95% confidence interval (CI)] was 97.5% (96.7% to 98.2%) at 6 months, 96.6% (95.6% to 97.4%) at 1 year, and 93.5% (91.9% to 94.8%) at 5 years. Probability of being alive and on follow-up was 80.8% (78.5% to 82.8%) at 5 years. Early mortality was associated with anemia [adjusted hazard ratio (aHR) 3.6, 95% CI: 1.7 to 7.5] and low CD4 count (aHR 1.6, 95% CI: 1.1 to 2.2 per 50 cells decrease) at treatment initiation. Long-term mortality was associated with persistent anemia (aHR 4.9, 95% CI: 2.1 to 11.6), CD4 increase from baseline ,50 cells per cubic millimeter (aHR 3.1, 95% CI: 1.6 to 5.7), and viral load >1000 copies per milliliter (aHR 2.8, 95% CI: 1.3 to 6.1) at 6 months of HAART; male gender; and calendar year of enrollment. Conclusions: Early mortality was associated with anemia and severe immunosuppression at initiation of therapy. Long-term mortality was associated with persistent anemia, CD4 count increase, and virological response at 6 months of therapy over baseline characteristics, highlighting the importance of laboratory monitoring. Copyright © 2012 by Lippincott Williams & Wilkins. 2018-09-04T06:11:27Z 2018-09-04T06:11:27Z 2012-05-01 Journal 10779450 15254135 2-s2.0-84862126574 10.1097/QAI.0b013e31824bd33f https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84862126574&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/51901
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
topic Medicine
spellingShingle Medicine
Federica Fregonese
Intira J. Collins
Gonzague Jourdain
Sophie LeCoeur
Tim R. Cressey
Nicole Ngo-Giang-Houng
Sukit Banchongkit
Apichat Chutanunta
Malee Techapornroong
Marc Lallemant
Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand
description Objective: To estimate the early and long-term mortalities and associated risk factors in adults receiving highly active antiretroviral therapy (HAART) in Thailand. Design: A prospective observational cohort study. Methods: Previously untreated adults starting HAART in 2002-2009 were followed-up in 43 public hospitals. Kaplan-Meier probability of survival was estimated up to 5 years of therapy. Factors associated with early (≤6 months) and long-term (>6 months) mortalities were assessed using Cox regression analyses. Results: A total of 1578 adults received HAART (74% women; median age, 33 years; CD4 cell count, 124/mL), with a median followup of 50 months (interquartile range, 41-66). Eighty-nine patients (6%) died (37 occurred ≤6 months and 52 occurred >6 months) and 183 (12%) were lost to follow-up. Probability of survival [95% confidence interval (CI)] was 97.5% (96.7% to 98.2%) at 6 months, 96.6% (95.6% to 97.4%) at 1 year, and 93.5% (91.9% to 94.8%) at 5 years. Probability of being alive and on follow-up was 80.8% (78.5% to 82.8%) at 5 years. Early mortality was associated with anemia [adjusted hazard ratio (aHR) 3.6, 95% CI: 1.7 to 7.5] and low CD4 count (aHR 1.6, 95% CI: 1.1 to 2.2 per 50 cells decrease) at treatment initiation. Long-term mortality was associated with persistent anemia (aHR 4.9, 95% CI: 2.1 to 11.6), CD4 increase from baseline ,50 cells per cubic millimeter (aHR 3.1, 95% CI: 1.6 to 5.7), and viral load >1000 copies per milliliter (aHR 2.8, 95% CI: 1.3 to 6.1) at 6 months of HAART; male gender; and calendar year of enrollment. Conclusions: Early mortality was associated with anemia and severe immunosuppression at initiation of therapy. Long-term mortality was associated with persistent anemia, CD4 count increase, and virological response at 6 months of therapy over baseline characteristics, highlighting the importance of laboratory monitoring. Copyright © 2012 by Lippincott Williams & Wilkins.
format Journal
author Federica Fregonese
Intira J. Collins
Gonzague Jourdain
Sophie LeCoeur
Tim R. Cressey
Nicole Ngo-Giang-Houng
Sukit Banchongkit
Apichat Chutanunta
Malee Techapornroong
Marc Lallemant
author_facet Federica Fregonese
Intira J. Collins
Gonzague Jourdain
Sophie LeCoeur
Tim R. Cressey
Nicole Ngo-Giang-Houng
Sukit Banchongkit
Apichat Chutanunta
Malee Techapornroong
Marc Lallemant
author_sort Federica Fregonese
title Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand
title_short Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand
title_full Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand
title_fullStr Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand
title_full_unstemmed Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand
title_sort predictors of 5-year mortality in hiv-infected adults starting highly active antiretroviral therapy in thailand
publishDate 2018
url https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84862126574&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/51901
_version_ 1681423853449904128